Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VXX
501
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $56.3M | 0.03% |
413,419
+381,219
| +1,184% | +$60.9M |
|
|
ALXN
502
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $56.2M | 0.03% |
458,400
-66,400
| -13% | -$8.55M |
|
|
RSX
503
PUT
DELISTED
VanEck Russia ETF
RSX
| $56.1M | 0.03% |
2,990,000
-738,000
| -20% | -$13.5M |
|
504
PUT
Royal Caribbean
RCL
$77.8B
| $56M | 0.03% |
747,500
+221,200
| +42% | +$15.6M |
|
505
CALL
Marriott International
MAR
$93.4B
| $55.9M | 0.03% |
830,500
+172,800
| +26% | +$12.2M |
|
506
PUT
Invesco CurrencyShares Japanese Yen Trust
FXY
$461M
| $55.9M | 0.03% |
587,000
+398,400
| +211% | +$37.6M |
|
|
POT
507
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $55.9M | 0.03% |
3,424,400
+105,200
| +3% | +$1.74M |
|
508
PUT
Energy Transfer Partners
ET
$72.8B
| $55.9M | 0.03% |
3,327,800
-1,324,000
| -28% | -$22.4M |
|
509
PUT
Gen Digital
GEN
$17.4B
| $55.7M | 0.03% |
2,219,200
+68,100
| +3% | +$1.55M |
|
510
CALL
ProShares Ultra QQQ
QLD
$13.7B
| $55.5M | 0.03% |
10,259,200
+7,355,200
| +253% | +$37.6M |
|
|
IOC
511
CALL
DELISTED
Interoil Corporation
IOC
| $55.5M | 0.03% |
1,089,400
-815,500
| -43% | -$40M |
|
512
PUT
Vanguard Real Estate ETF
VNQ
$39.2B
| $55.4M | 0.03% |
638,700
+218,100
| +52% | +$19.5M |
|
|
VMW
513
CALL
DELISTED
VMware, Inc
VMW
| $55.4M | 0.03% |
755,100
-586,500
| -44% | -$41.3M |
|
|
514
SPDR Gold Trust
GLD
$155B
| $55.1M | 0.03% |
438,477
-3,218,245
| -88% | -$410M |
|
515
PUT
WisdomTree India Earnings Fund ETF
EPI
$2.02B
| $54.9M | 0.03% |
2,540,300
+848,900
| +50% | +$18.2M |
|
516
PUT
GSK
GSK
$103B
| $54.7M | 0.03% |
1,013,920
+189,120
| +23% | +$10.4M |
|
517
CALL
Aflac
AFL
$59.1B
| $54.6M | 0.03% |
1,520,800
-1,956,800
| -56% | -$71.2M |
|
518
PUT
NetEase
NTES
$78.8B
| $54.4M | 0.03% |
1,130,000
+44,000
| +4% | +$1.87M |
|
519
CALL
D.R. Horton
DHI
$41.7B
| $54.2M | 0.03% |
1,793,600
-84,500
| -4% | -$2.71M |
|
520
Visteon
VC
$2.71B
| $53.9M | 0.03% |
751,958
-119,432
| -14% | -$8.35M |
|
521
PUT
Lowe's Companies
LOW
$121B
| $53.8M | 0.03% |
744,800
+285,200
| +62% | +$22.2M |
|
522
PUT
Hershey
HSY
$38.1B
| $53.7M | 0.03% |
561,900
+211,100
| +60% | +$22.3M |
|
523
CALL
Cheniere Energy
LNG
$57.8B
| $53.6M | 0.03% |
1,229,800
+182,800
| +17% | +$7.71M |
|
524
CALL
International Paper
IP
$21.7B
| $53.3M | 0.03% |
1,174,166
-351,226
| -23% | -$15.5M |
|
525
PUT
The Mosaic Company
MOS
$7.6B
| $53.3M | 0.03% |
2,179,300
+218,000
| +11% | +$5.94M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.